What is portal hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

What is Portal Hypertension

Portal hypertension is a clinical syndrome defined by pathologically elevated pressure in the portal venous system (>5 mm Hg), characterized by increased resistance to portal blood flow and the formation of portal-systemic collateral vessels that divert blood away from the liver. 1

Hemodynamic Definition

Portal hypertension exists when the hepatic venous pressure gradient (HVPG) exceeds 5 mm Hg (normal is 1-5 mm Hg). The condition becomes clinically significant portal hypertension (CSPH) when HVPG reaches ≥10 mm Hg—the threshold at which life-threatening complications develop, including esophageal varices and ascites. 1, 2

The HVPG is calculated as the difference between wedged hepatic venous pressure and free hepatic venous pressure, providing a direct measurement of sinusoidal pressure. 1

Pathophysiology

Portal hypertension develops through two mechanisms:

  • Fixed structural changes: Fibrosis, angiogenesis, regenerative nodules, and vascular occlusion that distort liver microcirculation
  • Dynamic changes: Increased vascular tone from imbalanced vasodilators and vasoconstrictors acting on hepatic stellate cells and myofibroblasts 1

The underlying principle follows the hydraulic equivalent of Ohm's law: Pressure = Resistance × Flow. Portal pressure increases progressively as intrahepatic resistance rises, followed by compensatory increases in blood flow as disease advances. 2

Anatomic Classification

Portal hypertension is classified by the anatomic site of obstruction:

  • Prehepatic: Splenic, mesenteric, or extrahepatic portal vein obstruction (e.g., portal vein thrombosis)
  • Intrahepatic: Parenchymal liver diseases—most commonly cirrhosis in Western countries
  • Posthepatic: Hepatic venous outflow obstruction (e.g., Budd-Chiari syndrome, right heart failure) 1, 3

This classification is critical because HVPG only accurately reflects sinusoidal pressure and provides useful data only in intrahepatic causes. In prehepatic or presinusoidal portal hypertension, HVPG measurements remain normal despite elevated portal pressures. 3

Clinical Significance and Prognostic Thresholds

Different HVPG values predict specific outcomes:

  • ≥10 mm Hg (CSPH): Risk of varices, ascites, and clinical decompensation increases
  • ≥12 mm Hg: Threshold for variceal bleeding risk; reducing HVPG below this level protects against hemorrhage
  • ≥16 mm Hg: Independently associated with higher mortality in both compensated and decompensated cirrhosis
  • ≥20 mm Hg: Predicts failure to control acute bleeding, early rebleeding, and death 1, 3

Major Complications and Mortality Impact

Portal hypertension drives the transition from compensated to decompensated cirrhosis. Ascites is the most common complication, developing in nearly 60% of patients within a decade of cirrhosis diagnosis. Once ascites appears, 5-year survival drops from 80% to 50% without liver transplantation. 1

Other grave complications include:

  • Variceal hemorrhage
  • Hepatorenal syndrome (HRS)—triggered by splanchnic arterial vasodilation
  • Spontaneous bacterial peritonitis
  • Dilutional hyponatremia
  • Hepatic encephalopathy

When cirrhosis becomes refractory to medical treatment, 1-year mortality ranges from 20% to 50%. 1

Common Pitfall

Cirrhosis is by far the most common cause of portal hypertension in Western countries, but clinicians must remember that portal hypertension can arise from any condition obstructing portal flow at any level. 1 Always characterize the anatomic location of obstruction, as this determines both diagnostic approach (HVPG is only useful for sinusoidal causes) and treatment strategy.

References

1
Guideline

acr appropriateness criteria® radiologic management of portal hypertension.

Journal of the American College of Radiology, 2021

Related Questions

Does portal hypertension contribute to systemic arterial hypertension or resistant hypertension?
What is the appropriate management of a bloody paracentesis in a patient with portal hypertension?
In a 29-year-old female with portal hypertension (possible non-cirrhotic portal hypertension or chronic liver disease), severe pulmonary arterial hypertension, mild ascites, bilateral pleural effusion, pericardial effusion, and diuretic-induced hypotension, who had an ultrasound elastography showing liver stiffness of 26 kPa, should she be considered cirrhotic or should the elastography be repeated after about one month?
When does portal hypertension develop?
What medication adjustments are recommended for a 29‑year‑old female with portal hypertension (possible non‑cirrhotic portal hypertension or chronic liver disease) and severe pulmonary hypertension with pericardial effusion, who is hypotensive (systolic 85‑90 mm Hg, diastolic 50‑60 mm Hg) and currently receiving spironolactone (lasilactone) 20/50 mg twice daily, ambrisentan, tadalafil, digoxin, linezolid, and norfloxacin, and who has fever, diarrhea, nausea, and vomiting?
Can cirrhosis of the liver cause kidney problems such as hepatorenal syndrome?
How should moxifloxacin 0.5%/dexamethasone 0.1% ophthalmic solution be administered?
In a child with adenoidal hypertrophy presenting with fever, mild cough, and increased nasal mucus but no rhinorrhea, what is the appropriate evaluation and management?
What are the causes of frequent unilateral eye blinking in a child?
What is the optimal management strategy for portal hypertension?
In a patient with serum sodium 132 mEq/L, potassium 2.42 mEq/L, and chloride 96.5 mEq/L, which intravenous fluid should be selected for replacement?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.